肠道菌群
酿酒酵母
生物化学
生物
脂肪肝
丁酸盐
受体
内分泌学
β氧化
内科学
葡萄糖稳态
微生物群
化学
脂肪酸
表型
胰岛素受体
肉碱
代谢途径
肝X受体
小肠
新陈代谢
胰岛素抵抗
脂肪变性
炎症体
酶
作者
Shuping Qiao,S Y Fan,Juan Xu,Zhen Xu,Chen Peng,Junxing Qu,Ziqian Bing,Shizhen Zhou,Sunan Shen,Guifang Xu,Yue Zhao,Tingting Wang
标识
DOI:10.1002/advs.202514830
摘要
Accumulating evidence suggests that the intestinal microbiota participates in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) through microbiota-host interaction. However, the beneficial role of commensal mycobiota in MASLD progression remains poorly understood. By comparing the gut microbiome differences, we demonstrated that the deficiency of Caspase Recruitment Domain-containing protein 9 (CARD9), an adaptor protein for a microbiota recognition receptor, exacerbated high-fat diet (HFD)-induced MASLD in a gut fungi-dependent manner. CARD9 deficiency reduced the abundance of Saccharomyces cerevisiae (S. cerevisiae), which was a probiotic alleviating MASLD progression. S. cerevisiae promoted a significantly greater abundance of 5-hydroxyindoleacetic acid (5-HIAA) in the intestine through Toll-like receptor 1 (TLR1), which reduced body weight in mice and alleviated MASLD phenotypes via the "gut-liver" axis. Particularly, 5-HIAA directly binds to aryl-hydrocarbon receptor (AhR) and stimulates its nuclear translocation, subsequently inducing fatty acid oxidation via carnitine palmitoyltransferase 1A (CPT1A) and acyl-CoA oxidase 1 (ACOX1) transactivation. MASLD patients exhibited decreased levels of S. cerevisiae and 5-HIAA, and S. cerevisiae effectively reduced hepatic steatosis and improved glucose homeostasis in patients with MASLD. In summary, our findings identified a novel pathway of fungi-S. cerevisiae stimulating intestinal 5-HIAA production and indicated that S. cerevisiae and 5-HIAA might alleviate MASLD progression, highlighting that the mycobiota-dependent gut-liver axis was a promising target for the prevention of MASLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI